A novel vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation and the risk of bleeding Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
Association of diffuse alveolar hemorrhage with VKORC1, CYP2C9, and CYP2C19 polymorphisms Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010
Genetic polymorphisms in the cytochromes P450, microsomal epoxide hydrolase and glutathione S-transferase M1, T1 and P1 genes and their relationship to relapsing bronchitis and pneumonia in case of children Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005
Cytochrome P450 1A1 polymorphism and severity of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002
Interaction of GSTMI null variant and cytochrome P-450 type 1A1 Ile462Val polymorphism and susceptibility to COPD Source: Eur Respir J 2002; 20: Suppl. 38, 94s Year: 2002
Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD Source: Eur Respir J 2004; 23: 818-824 Year: 2004
Detoxifying enzymes genes (EPHX1, CYP1A1 and GSTP1) genotypes and risk of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 196s Year: 2003
Association analysis between polymorphisms in the cytochrome P450 2J2, 2S1 and UDP-glucuronosyltransferase 2B7 genes with occupational chronic bronchitis Source: Annual Congress 2010 - Genetics of obstruction Year: 2010
Polymorphisms for epoxide hydrolase, glutathione transferase and genetic susceptibility to COPD Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
CYP1A1, CYP1A2, CYP1B1, CYP2E1 polymorphisms and the risk of occupational chronic bronchitisSource: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD Source: Eur Respir J 2001; 18: 122S-126S Year: 2001
Association of polymorphisms of cytochrome P450 genes (CYP1A1 and CYP1A2 ) with chronic obstructive pulmonary disease in Tatars and Russians from Bashkortostan Source: Eur Respir J 2007; 30: Suppl. 51, 21s Year: 2007
C677T polymorphism of methilenetetrahydrofolate reductase gene and high altitude pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 400s Year: 2006
Risk of antituberculosis drug (ATD)-induced hepatotoxicity and polymorphisms at the glutatione S-transferase (GST) loci (GSTM1 and GSTT1) Source: Eur Respir J 2006; 28: Suppl. 50, 342s Year: 2006
Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD Source: Eur Respir J 2008; 32: 931-937 Year: 2008
Genetic polymorphism of epoxide hydrolase and GSTM1 in lung cancer susceptibility Source: Eur Respir J 2002; 20: Suppl. 38, 229s Year: 2002
Common variants of the microsomal epoxide hydrolase and glutamate-cysteine ligase in European populations are not associated with susceptibility to COPD Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
N-acetyltransferase 2 and CYP2E1 polymorphisms do not increase the risk of antituberculosis drug-induced hepatotoxicity in caucasian population Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008
Effects of aryl hydrocarbon receptor and cytochrome P450 1A1 polymorphisms on childhood lung function and asthma Source: Eur Respir J 2007; 30: Suppl. 51, 296s Year: 2007
Cytochrome P450 pharmacogenetics: a possible predictor of pulmonary drug induced toxicity? Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007